Last reviewed · How we verify
NCT06911853: 3I in action
Enhancing Clinical and Cultural Virtual Encounter in Health Professional Students: 3 Is (Internationalization, Innovation, Interdisciplinary) in Action
NA trial testing Virtual Reality Videos in Interprofessional Education in 104 participants. Completed in 31 August 2023.
31 August 2023
Quick facts
| Lead sponsor | The University of Hong Kong |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 104 |
| Start date | 1 September 2022 |
| Primary completion | 31 August 2023 |
| Estimated completion | 31 August 2023 |
| Sites | 1 location across Hong Kong |
Drugs / interventions tested
- Virtual Reality Videos
Conditions studied
- Interprofessional Education — all drugs for Interprofessional Education →
Sponsor
The University of Hong Kong
Who can join
Adults 18 to 40, any sex, with Interprofessional Education. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a cross-over randomized control study with 3 time-points' measurement. This study is mainly to evaluate if the online pedagogic innovative learning modules could benefit students through their interprofessional and intercultural virtual encounters, with a focus on assessing their cultural awareness, interprofessional attitude and online learning engagement.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06911853
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Virtual Reality Videos
Trials testing the same drug.
- NCT07088367 — Virtual Reality Meditation on Anxiety in Cancer Patients Receiving Chemotherapy · NA · completed
Other The University of Hong Kong trials
Trials by the same sponsor.
- NCT05981430 — Fecal Microbiota Transplantation for Decolonization of Carbapenem-resistant Enterobacteriaceae · NA · not yet recruiting
- NCT07478757 — Assessing the Effectiveness of Low-Dose Computed Tomography in Lung Cancer Screening for High-Risk Smokers: A Randomized · NA · not yet recruiting
- NCT07448649 — Chatbot-Assisted Advance Care Planning Education for Family Members · NA · not yet recruiting
- NCT07484932 — TRTRM (ACTTOP) -Guided Dosing Strategy in Older Patients With Cancer · NA · not yet recruiting
- NCT07531589 — BrainLive Connect: Non-professional Delivered CST for People Living With Dementia · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06911853 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The University of Hong Kong
- Last refreshed: 4 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06911853.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing